Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

Genetic testing should be offered to myeloma patients to identify high-risk cases earlier and enable more targeted and effective treatment, according to experts. A study by The Institute of Cancer ...

CHATSWORTH, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized ...

Hetty Carraway, MD: We didn’t go through all the details of the cytogenetic testing, and I’m not sure we need to other than to say that there are specific types of chromosomal aberrations that put ...

A DNA index cutoff ≥1.10 delivered excellent discrimination for HHD (AUC 0.947) with high sensitivity and near-rule-out performance when negative (NPV 99.1%). Karyotype failure occurred in 25.2%, and ...

Identification of recurrent genetic abnormalities is important for disease evaluation, optimal risk stratification and treatment planning. Testing for recurrent genetic abnormalities should be ...

Neuberg Sehgal Path Lab, a leading name in diagnostic services, has announces the launch of cutting-edge cytogenetics testing technology at its facilities in Mumbai. This advanced diagnostic tool is ...

New research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately. Sometimes even better than all existing techniques together, ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...